NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992

被引：41

作者：

DIMASI, JA

SEIBRING, MA

LASAGNA, L

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1994年 / 55卷 / 06期

关键词：

D O I：

10.1038/clpt.1994.78

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：609 / 622

页数：14

共 21 条

[1] BIOPHARMACEUTICALS AND CONVENTIONAL DRUGS - CLINICAL SUCCESS RATES [J].

BIENZTADMOR, B ;

DICERBO, PA ;

TADMOR, G ;

LASAGNA, L .

BIO-TECHNOLOGY, 1992, 10 (05) :521-525

[2] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].

DIMASI, JA ;

HANSEN, RW ;

GRABOWSKI, HG ;

LASAGNA, L .

JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) :107-142

[3] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990 [J].

DIMASI, JA ;

BRYANT, NR ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :471-486

[4]

KAITIN KI, 1992, DRUG INF J, V26, P341

[5] NEW DRUG DEVELOPMENT IN THE UNITED-STATES, 1963 THROUGH 1984 [J].

MATTISON, N ;

TRIMBLE, AG ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (03) :290-301

[6] NEW DRUG DEVELOPMENT DURING AND AFTER A PERIOD OF REGULATORY CHANGE - CLINICAL RESEARCH ACTIVITY OF MAJOR UNITED-STATES PHARMACEUTICAL FIRMS, 1958 TO 1979 [J].

MAY, MS ;

WARDELL, WM ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :691-700

[7]

TEMPLE R, 1993, DRUG INF J, V27, P355

[8] DEVELOPMENT OF NEW DRUGS ORIGINATED AND ACQUIRED BY UNITED-STATES-OWNED PHARMACEUTICAL FIRMS, 1963-1976 [J].

WARDELL, WM ;

DIRADDO, J ;

TRIMBLE, AG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :270-277

[9]

WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P133

[10] NEW DRUG DEVELOPMENT BY UNITED-STATES PHARMACEUTICAL FIRMS WITH ANALYSES OF TRENDS IN THE ACQUISITION AND ORIGIN OF DRUG CANDIDATES, 1963-1979 [J].

WARDELL, WM ;

MAY, MS ;

TRIMBLE, AG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (04) :407-417

← 1 2 3 →